Voleon Capital Management LP Amgen Inc Transaction History

Voleon Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $3.64 Million - $4.83 Million	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $13.6 Million - $17.5 Million	-72,000 Reduced 78.26%	20,000 $4.82 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2.26 Million - $2.71 Million	13,000 Added 16.46%	92,000 $17.8 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $666,800 - $781,640	4,000 Added 5.33%	79,000 $14.6 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $4.52 Million - $5.1 Million	-25,000 Reduced 25.0%	75,000 $14.2 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $17.8 Million - $20.8 Million	100,000 New	100,000 $19.5 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Voleon Capital Management LP with notifications on news.